ALNYAlnylam PharmaceuticalsALNY info
$274.95info0.18%24h
Global rank529
Market cap$34.34B
Change 7d7.09%
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare

Alnylam Pharmaceuticals (ALNY) Total Liabilities

ALNY Total Liabilities in 2022: $4.05B

According to Alnylam Pharmaceuticals latest financial reports the total liabilities of ALNY is $4.05B, an increase of 9.34% to 2022. At the end of 2022 company had $3.70B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Alnylam Pharmaceuticals is responsible for during its operational activities.

Alnylam Pharmaceuticals (ALNY) Total Liabilities History from 2023 to 2022

-
Value:-

ALNY Total Liabilities by year

YearTotal liabilitiesChange
2023$4.05B9.34%
2022$3.70B21.26%
2021$3.06B27.78%
2020$2.39B149.97%
2019$956.44M840.08%
2018$101.74M-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org